Source:http://linkedlifedata.com/resource/pubmed/id/18592403
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2008-11-17
|
pubmed:abstractText |
We replaced the HIV-1 nucleocapsid (NC) domain with different N-coding sequences to test SARS-CoV nucleocapsid (N) self-interaction capacity, and determined the capabilities of each chimera to direct virus-like particle (VLP) assembly. Analysis results indicate that the replacement of NC with the carboxyl-terminal half of the SARS-CoV N resulted in the production of wild type (wt)-level virus-like particles (VLPs) with the density of a wt HIV-1 particle. When co-expressed with SARS-CoV N, chimeras containing the N carboxyl-terminal half sequence efficiently packaged N. However, the same was not true for the chimera bearing the N amino-terminal half sequence, despite its production of substantial amounts of VLPs. According to further analysis, HIV-1 NC replacement with N residues 2-213, 215-421, or 234-421 resulted in efficient VLP production at levels comparable to that of wt HIV-1, but replacement with residues 215-359, 302-421, 2-168, or 2-86 failed to restore VLP production to wild-type levels. The results suggest that the domain conferring the ability to direct VLP assembly and release in SARS-CoV N is largely contained between residues 168 and 421.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1423-0127
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
719-29
|
pubmed:meshHeading |
pubmed-meshheading:18592403-Cell Line,
pubmed-meshheading:18592403-Centrifugation, Density Gradient,
pubmed-meshheading:18592403-HIV,
pubmed-meshheading:18592403-Humans,
pubmed-meshheading:18592403-Nucleocapsid Proteins,
pubmed-meshheading:18592403-Peptide Mapping,
pubmed-meshheading:18592403-Recombinant Fusion Proteins,
pubmed-meshheading:18592403-SARS Virus,
pubmed-meshheading:18592403-Sucrose,
pubmed-meshheading:18592403-Virion
|
pubmed:year |
2008
|
pubmed:articleTitle |
Severe acute respiratory syndrome coronavirus nucleocapsid protein confers ability to efficiently produce virus-like particles when substituted for the human immunodeficiency virus nucleocapsid domain.
|
pubmed:affiliation |
Institute of Public Health, National Yang-Ming University, Taipei, Taiwan, ROC.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|